loader

Cocrystal Pharma

NASDAQ:COCP

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and...

Featured Articles and Interviews

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Press Releases

Cocrystal Pharma Presents Positive Preclinical Data for CC-42344

Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Interactive Chart

×